QR koda

Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited

Shranjeno v:
Bibliografske podrobnosti
Principais autores: Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis Group 2019-05-01
Serija:Blood Pressure
Online dostop:http://dx.doi.org/10.1080/08037051.2019.1614278
Oznake: Označite
Brez oznak, prvi označite!